Stanley Laman Group, Ltd. Eli Lilly & CO Transaction History

Stanley Laman Group, Ltd.

$648 Million
Q3 2024

A detailed history of Stanley Laman Group, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 5,280 shares of LLY stock, worth $4.05 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

5,280

Previous 5,383 1.91%

Holding current value

$4.05 Million

Previous $4.87 Million 4.02%

% of portfolio

0.72%

Previous 0.77%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $79,530 - $98,882	-103 Reduced 1.91%	5,280 $4.68 Million
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $3.22 Million - $4.03 Million	-4,438 Reduced 45.19%	5,383 $4.87 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $1.23 Million - $1.64 Million	-2,073 Reduced 17.43%	9,821 $7.64 Million
Q4 2023 Feb 02, 2024	SELL	$525.19 - $619.13 $818,246 - $964,604	-1,558 Reduced 11.58%	11,894 $6.93 Million
Q3 2023 Oct 16, 2023	SELL	$434.7 - $599.3 $259,515 - $357,782	-597 Reduced 4.25%	13,452 $7.23 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $588,541 - $786,948	-1,678 Reduced 10.67%	14,049 $6.59 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $37,896 - $44,508	-122 Reduced 0.77%	15,727 $5.4 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $212,866 - $248,031	-662 Reduced 4.01%	15,849 $0
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $237,776 - $270,971	-802 Reduced 4.63%	16,511 $5.34 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $470,774 - $552,759	-1,689 Reduced 8.89%	17,313 $5.61 Million
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $551,521 - $685,401	2,350 Added 14.11%	19,002 $5.44 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $319,736 - $396,794	1,422 Added 9.34%	16,652 $4.6 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $279,437 - $343,887	1,261 Added 9.03%	15,230 $3.52 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $235,437 - $304,536	1,304 Added 10.3%	13,969 $3.21 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $123,897 - $160,390	754 Added 6.33%	12,665 $2.37 Million
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $80,493 - $106,512	-617 Reduced 4.92%	11,911 $2.01 Million
Q3 2020 Oct 20, 2020	BUY	$146.22 - $169.13 $1.83 Million - $2.12 Million	12,528 New	12,528 $1.85 Million
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $273,112 - $328,688	-2,002 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $238,338 - $294,994	2,002 New	2,002 $278,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Eli Lilly & CO Transaction History